Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 01 2021
Historique:
received: 09 08 2020
accepted: 07 12 2020
entrez: 13 1 2021
pubmed: 14 1 2021
medline: 11 8 2021
Statut: epublish

Résumé

To assess mortality trends at 1 and 3 years from 2001 to 2018 in a real-life cohort of HF outpatients from different etiologies with depressed and preserved LVEF. A total of 2368 consecutive patients with HF (mean age 66.4 ± 12.9 years, 71% men, 15.4% with preserved LVEF) admitted to a HF clinic from August 2001 to September 2018 were included in the study. Patients were divided into five quintiles (Q) according to the period of admission. Trends for all-cause and cardiovascular mortality from Q1 to Q5 were assessed by linear regression. Patients with LVEF < 50% had a progressive decrease in the rates of all-cause and cardiovascular death at 1 year (12.1% in Q1 to 6.5% in Q5, p = 0.003; and 8.4% in Q1 to 3.8% in Q5, p = 0.007, respectively) and 3 years (30.5% in Q1 to 17.0% in Q5, p = 0.003; and 23.9% in Q1 to 9.8% in Q5, p = 0.003, respectively). These trends remained significant after adjusting for clinical characteristics and risk. No significant trend in mortality was observed in patients with LVEF ≥ 50%. In a cohort of real-life ambulatory patients with HF, mortality progressively declined in patients with LVEF < 50%, but the same trend was not observed in patients with preserved LVEF.

Identifiants

pubmed: 33436787
doi: 10.1038/s41598-020-79926-3
pii: 10.1038/s41598-020-79926-3
pmc: PMC7804393
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

732

Références

Circulation. 2004 Oct 26;110(17):2618-26
pubmed: 15492298
Heart. 2018 Mar;104(5):407-415
pubmed: 28780577
Eur J Gen Pract. 2010 Dec;16(4):205-14
pubmed: 21073267
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
N Engl J Med. 1999 Sep 2;341(10):709-17
pubmed: 10471456
N Engl J Med. 2019 Oct 24;381(17):1609-1620
pubmed: 31475794
N Engl J Med. 2005 Jan 20;352(3):225-37
pubmed: 15659722
N Engl J Med. 2011 Jan 6;364(1):11-21
pubmed: 21073363
ESC Heart Fail. 2020 Feb;7(1):194-212
pubmed: 31978280
J Am Coll Cardiol. 2012 May 8;59(19):1709-15
pubmed: 22554602
N Engl J Med. 2014 Sep 11;371(11):993-1004
pubmed: 25176015
Circulation. 2016 Jul 5;134(1):73-90
pubmed: 27358439
N Engl J Med. 1991 Aug 1;325(5):293-302
pubmed: 2057034
Eur J Heart Fail. 2020 Jun;22(6):1032-1042
pubmed: 32293090
Eur J Heart Fail. 2016 Apr;18(4):402-10
pubmed: 26754527
Circ Heart Fail. 2018 Jun;11(6):e004646
pubmed: 29793934
Circulation. 2015 Jan 20;131(3):269-79
pubmed: 25398313
J Am Coll Cardiol. 2017 Nov 14;70(20):2476-2486
pubmed: 29141781
N Engl J Med. 2001 May 31;344(22):1651-8
pubmed: 11386263
J Am Coll Cardiol. 2018 Aug 7;72(6):591-601
pubmed: 30071987
JACC Heart Fail. 2018 Aug;6(8):619-632
pubmed: 30071950
N Engl J Med. 2005 Apr 14;352(15):1539-49
pubmed: 15753115
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Curr Heart Fail Rep. 2013 Dec;10(4):373-9
pubmed: 23943315
JACC Heart Fail. 2019 Jan;7(1):13-21
pubmed: 30606482
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366
pubmed: 30025570
Lancet. 1999 Jan 2;353(9146):9-13
pubmed: 10023943
Curr Heart Fail Rep. 2017 Apr;14(2):59-70
pubmed: 28247180
JACC Heart Fail. 2018 Aug;6(8):678-685
pubmed: 30007560

Auteurs

Giosafat Spitaleri (G)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Josep Lupón (J)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.
Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.
CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.

Mar Domingo (M)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Evelyn Santiago-Vacas (E)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Pau Codina (P)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Elisabet Zamora (E)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.
Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.
CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.

Germán Cediel (G)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.
Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.

Javier Santesmases (J)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.
Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.

Crisanto Diez-Quevedo (C)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Maria Isabel Troya (MI)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Maria Boldo (M)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Salvador Altmir (S)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Nuria Alonso (N)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Beatriz González (B)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain.

Julio Núñez (J)

CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.
Cardiology Department, Hospital Clínico Universitario, INCLIVA, València, Spain.
Department of Medicine, Universitat de València, València, Spain.

Antoni Bayes-Genis (A)

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias I Pujol, Badalona, Spain. abayesgenis@gmail.com.
Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain. abayesgenis@gmail.com.
CIBERCV, Instituto de Salud Carlos III, Madrid, Spain. abayesgenis@gmail.com.
Heart Institute, Hospital Universitari Germans Trias I Pujol, Department of Medicine, Universitat Autonoma de Barcelona, Carretera del Canyet s/n 08916, Badalona, Spain. abayesgenis@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH